Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,637.08
(
2.01%
)
US TECH 100
23,726.80
(
1.91%
)
Dow Jones
46,588.10
(
2.22%
)
Brent Oil
97.97
(
-9.40%
)
Bitcoin
71,473.99
(
5.36%
)
News Focus
News Focus
Post# of 257269
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: jbog post# 113228

Tuesday, 01/25/2011 5:21:37 PM

Tuesday, January 25, 2011 5:21:37 PM

Post# of 257269
MNTA: Nice miss, Jbog:

Momenta Pharma thesis unchanged on Teva news, says Cowen
Cowen continues to believe Momenta's M-Enoxaprin is worth mid $20's to shares and reiterates its Outperform rating

"If we don't succeed, we run the risk of failure."
-Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today